Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -21.12% is in line with its 5-year average of -21.98%, near the low end of its 5-year range (-31.49%–15.73%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.97% above its 12-month average of -22.95%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -21.12%.
RETURN ON INVESTED CAPITAL (ROIC)
-21.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-22.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-19.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-21.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-22.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+7.97%
CURRENT VS 3Y AVG
-6.59%
CURRENT VS 5Y AVG
+3.91%
CURRENT VS 10Y AVG
+7.59%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.40%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-351.47%
vs the sector median at left
CRISPR Therapeutics AG
Market Cap
$5.35B
Return on Invested Capital (ROIC)
-21.12%
TTM Avg
-22.95%
3Y Avg
-19.82%
5Y Avg
-21.98%
Market Cap
$5.22B
Return on Invested Capital (ROIC)
15.35%
TTM Avg
17.38%
3Y Avg
14.85%
5Y Avg
17.21%
Market Cap
$5.10B
Return on Invested Capital (ROIC)
5.80%
TTM Avg
5.65%
3Y Avg
5.40%
5Y Avg
4.23%
Market Cap
$5.61B
Return on Invested Capital (ROIC)
-90.04%
TTM Avg
-83.71%
3Y Avg
-67.61%
5Y Avg
-57.95%
Market Cap
$6.47B
Return on Invested Capital (ROIC)
-4.30%
TTM Avg
9.38%
3Y Avg
-2.79%
5Y Avg
-9.92%
Market Cap
$6.63B
Return on Invested Capital (ROIC)
19.48%
TTM Avg
18.99%
3Y Avg
19.98%
5Y Avg
22.15%
Market Cap
$2.76B
Return on Invested Capital (ROIC)
5.87%
TTM Avg
7.96%
3Y Avg
-0.22%
5Y Avg
-9.17%
Market Cap
$8.02B
Return on Invested Capital (ROIC)
22.98%
TTM Avg
-12.21%
3Y Avg
-17.44%
5Y Avg
-20.18%
Market Cap
$2.52B
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-36.25%
3Y Avg
-29.21%
5Y Avg
-30.95%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | $5.35B | -21.12% | -22.95% | -19.82% | -21.98% |
| Doximity, Inc. (DOCS)vs › | $5.22B | 15.35% | 17.38% | 14.85% | 17.21% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 5.80% | 5.65% | 5.40% | 4.23% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | -90.04% | -83.71% | -67.61% | -57.95% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | -4.30% | 9.38% | -2.79% | -9.92% |
| Chemed Corporation (CHE)vs › | $6.63B | 19.48% | 18.99% | 19.98% | 22.15% |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 5.87% | 7.96% | -0.22% | -9.17% |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 22.98% | -12.21% | -17.44% | -20.18% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -28.96% | -36.25% | -29.21% | -30.95% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -49.78% | -43.13% | -47.40% | -42.10% |
ROIC
-21.1%
ROE
-25.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -21.12% |
| 2026-03-31 | -21.24% |
| 2025-12-31 | -26.62% |
| 2025-09-30 | -22.30% |
| 2025-06-30 | -23.48% |
| 2025-03-31 | -22.98% |
| 2024-12-31 | -21.49% |
| 2024-09-30 | -15.23% |
| 2024-06-30 | -15.92% |
| 2024-03-31 | -12.78% |
| 2023-12-31 | -10.42% |
| 2023-09-30 | -21.28% |
| 2023-06-30 | -22.78% |
| 2023-03-31 | -26.58% |
| 2022-12-31 | -31.49% |
| 2022-09-30 | -31.05% |
| 2022-06-30 | -26.95% |
| 2022-03-31 | 12.10% |
| 2021-12-31 | 13.89% |
| 2021-09-30 | 14.87% |
| 2021-06-30 | 15.73% |
| 2021-03-31 | -20.95% |
| 2020-12-31 | -20.31% |
| 2020-09-30 | -16.70% |
| 2020-06-30 | -0.40% |
| 2020-03-31 | 2.21% |
| 2019-12-31 | 4.56% |
| 2019-09-30 | -1.47% |
| 2019-06-30 | -42.35% |
| 2019-03-31 | -38.02% |
| 2018-12-31 | -34.46% |
| 2018-09-30 | -23.17% |
| 2018-06-30 | -25.96% |
| 2018-03-31 | -19.69% |
| 2017-12-31 | -25.17% |
| 2017-09-30 | -33.65% |
| 2017-06-30 | -28.35% |
| 2017-03-31 | -25.28% |
| 2016-12-31 | -21.10% |
| 2016-09-30 | -27.42% |
| 2016-06-30 | -21.92% |
| 2016-03-31 | -20.22% |
| 2015-12-31 | -17.24% |
